| 社区获得性肺炎两种治疗方案的成本-效果分析 |
| 投稿时间：2013-05-08 修订日期：2013-11-12 点此下载全文 |
| 引用本文：张利芳,徐蓝.社区获得性肺炎两种治疗方案的成本-效果分析[J].药学实践杂志,2014,32(4):315~317 |
| 摘要点击次数: 1387 |
| 全文下载次数: 72 |
|
|
| 中文摘要:目的 评价两种治疗方案对治疗社区获得性肺炎的药物经济学效果,指导合理用药。方法 对两种治疗方案运用成本-效果分析法进行分析。结果 两种治疗方案中,单用莫西沙星(A组)总成本为4 092.75元,联合使用阿奇霉素和头孢呋辛(B组)总成本为3 306.83元;有效率分别为88.89%和85.71%;单位效果的增量成本分别为46.04元和38.58元。结论 联合使用阿奇霉素和头孢呋辛治疗社区获得性肺炎更为经济合理。 |
| 中文关键词:成本-效果分析 药物经济学 社区获得性肺炎 |
| |
| Cost-effectiveness analysis of community-acquired pneumonia therapeutic treatments |
|
|
| Abstract:Objective To evaluate the pharmacoeconomics effectiveness of two community-acquired pneumonia therapeutic treatments, and provide guidance for rational drug use.Methods Two therapeutic schemes were analyzed through cost-effectiveness analysis.Result Between the two treatments, the total cost by using moxifloxacin alone (Group A) was 4 092.75 RMB, while that of using azithromycin and cefuroxime (Group B) combined was 3 306.83 RMB; the effective rates were 88.89% and 85.71%, respectively; the incremental cost for each effect unit of these two treatments was 46.04 RMB and 38.58 RMB.Conclusion It is more economical and reasonable to use azithromycin and cefuroxime combination for the therapeutic treatment of community-acquired pneumonia. |
| keywords:cost-effectiveness analysis pharmacoeconomics community-acquired pneumonia |
| 查看全文 查看/发表评论 下载PDF阅读器 |
|
| 关闭 |
